Zapping the brain with electricity may help MS patients think sharper
NCT ID NCT07160218
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 33 times
Summary
This study tested whether a gentle electrical current applied to the brain (tDCS) combined with computer-based cognitive training could improve memory, attention, and brain flexibility in people with multiple sclerosis. Forty-five adults with relapsing-remitting MS took part. The goal was to see if these treatments could help with common thinking problems and promote positive changes in the brain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shahid Beheshti University of Medical Science
Tehran, Iran
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial direct current stimulation (tDCS) and computer-based cognitive rehabilitation exercises
What this could lead to
If it works, this could point toward a non-drug way to help MS patients think more clearly and remember better.
What could go wrong
This is a small, early-stage trial with only 45 participants. The improvements may be modest or not last long, and the results may not apply to all MS patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.